Bayer shares rose 10% after a Philadelphia appeals court ruled in favor of the company over claims it had failed to place a cancer warning label on the Roundup weedkiller made by its subsidiary Monsanto.
Bayer shares rose 10% after a Philadelphia appeals court ruled in favor of the company over claims it had failed to place a cancer warning label on the Roundup weedkiller made by its subsidiary Monsanto.